Results 201 to 206 of about 28,270 (206)

Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist

Cardiovascular Therapeutics, 2009
Steen Husted, J J J Van Giezen
exaly  

Adenosine-Mediated Effects of Ticagrelor

Journal of the American College of Cardiology, 2014
Marco Cattaneo, Rainer Schulz, Sven Nylander   +2 more
exaly  

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Circulation, 2016
Francesco Franchi, Fabiana Rollini, Jung Rae Cho   +2 more
exaly  

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

Lancet, The, 2010
Stefan James, Robert F Storey, Jay Horrow   +2 more
exaly  

Pharmacodynamic Effects During the Transition Between Cangrelor and Ticagrelor

JACC: Cardiovascular Interventions, 2014
David J Schneider, Naveen Seecheran
exaly  

Ticagrelor

Reactions Weekly, 2014
openaire   +1 more source